TRACON Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.51 | -$1.51 | -$1.51 |
| Q2 2024 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q3 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
TRACON Pharmaceuticals, Inc. Earnings Date And Information
TRACON Pharmaceuticals, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.94 earnings per share for the quarter, topping analysts' consensus estimates of $-1.05 by $0.11. The company had revenue of 55,000 for the quarter and had revenue of 12.05 M for the year. TRACON Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.19 diluted earnings per share) and currently has a price-to-earnings ratio of 0.02. TRACON Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
TRACON Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$1.05 | -$0.94 | 0.11 | $55,000 | $55,000 |
| 05/14/2024 | Q1 2024 | -$1.20 | -$1.33 | -0.13 | $100,000 | |
| 03/05/2024 | Q4 2023 | -$0.60 | $0.22 | 0.82 | $3.05 M | |
| 11/09/2023 | Q3 2023 | -$0.06 | $5.85 | 5.91 | $3.55 M | $0 |
| 08/14/2023 | Q2 2023 | -$0.36 | -$4.09 | -3.73 | $3.00 M | $9.00 M |
| 05/10/2023 | Q1 2023 | -$0.29 | -$9.18 | -8.89 | $0 | |
| 03/08/2023 | Q4 2022 | -$0.28 | -$6.49 | -6.21 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.30 | -$6.05 | -5.75 | $0 | |
| 08/10/2022 | Q2 2022 | -$0.29 | -$6.13 | -5.84 | $0 | |
| 05/11/2022 | Q1 2022 | -$0.41 | -$9.66 | -9.25 | $0 | |
| 03/15/2022 | Q4 2021 | -$0.40 | -$7.93 | -7.53 | $-346,000 | |
| 11/03/2021 | Q3 2021 | -$0.32 | -$7.50 | -7.18 | $70,000 | $0 |
| 08/11/2021 | Q2 2021 | -$0.34 | -$11.60 | -11.26 | $346,000 | |
| 05/05/2021 | Q1 2021 | -$0.32 | -$6.54 | -6.22 | $0 | |
| 02/25/2021 | Q4 2020 | -$0.34 | -$6.25 | -5.91 | $0 | |
| 11/10/2020 | Q3 2020 | -$0.61 | -$7.60 | -6.99 | $0 | |
| 08/05/2020 | Q2 2020 | -$0.74 | -$13.94 | -13.2 | $0 | |
| 05/13/2020 | Q1 2020 | -$0.99 | -$15.55 | -14.56 | $0 | |
| 02/27/2020 | Q4 2019 | -$24.91 | $0 | |||
| 11/05/2019 | Q3 2019 | -$2.00 | -$34.73 | -32.73 | $0 |
TRACON Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is TRACON Pharmaceuticals, Inc.'s earnings date?
TRACON Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did TRACON Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, TRACON Pharmaceuticals, Inc. (:TCON) reported $-0.94 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.05 by $0.11.
-
How can I listen to TRACON Pharmaceuticals, Inc.'s earnings conference call?
The conference call for TRACON Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read TRACON Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for TRACON Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does TRACON Pharmaceuticals, Inc. generate each year?
TRACON Pharmaceuticals, Inc. (:TCON) has a recorded annual revenue of $12.05 M.
-
How much profit does TRACON Pharmaceuticals, Inc. generate each year?
TRACON Pharmaceuticals, Inc. (:TCON) has a recorded net income of $12.05 M. TRACON Pharmaceuticals, Inc. has generated $-2.2 earnings per share over the last four quarters.
-
What is TRACON Pharmaceuticals, Inc.'s price-to-earnings ratio?
TRACON Pharmaceuticals, Inc. (:TCON) has a price-to-earnings ratio of 0.02 and price/earnings-to-growth ratio is 0.
